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Compared to traditional testing strategies, nucleic acid amplification tests such as real-time PCR offer many
advantages for the detection of human adenoviruses. However, commercial assays are expensive and cost
prohibitive for many clinical laboratories. To overcome fiscal challenges, a cost effective strategy was developed
using a combination of homogenization and heat treatment with an “in-house” real-time PCR. In 196 swabs
submitted for adenovirus detection, this crude extraction method showed performance characteristics equivalent to
viral DNA obtained from a commercial nucleic acid extraction. In addition, the in-house real-time PCR outperformed
traditional testing strategies using virus culture, with sensitivities of 100% and 69.2%, respectively. Overall, the
combination of homogenization and heat treatment with a sensitive in-house real-time PCR provides accurate
results at a cost comparable to viral culture.
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Human adenoviruses (HAdV) are ubiquitous DNA viruses
that cause a wide spectrum of illness [1]. The majority of
HAdVs cause mild and self-limiting respiratory tract infec-
tions, gastroenteritis or conjunctivitis; however, more severe
disease can occur such as kerato-conjunctivitis, pneumon-
itis, and disseminated disease in the immunodeficient host
[2-5]. HAdV is increasingly being recognized as a signifi-
cant viral pathogen, particularly in immunocompromized
patients where accurate and timely diagnosis can play an
integral part of management [6-12].
HAdV diagnosis can be achieved using virus culture,
antigen-based methods (immunofluorescence, enzyme
immunoassays or immunochromatography), or nucleic
acid amplification tests (NAATs). For respiratory viruses,
NAATs are well established as the most sensitive methods
for detection and have become front-line diagnostic pro-
cedures [7,13-18]. Most commercially available NAATs
are highly multiplexed assays and enable simultaneous* Correspondence: jason.leblanc@cdha.nshealth.ca
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reproduction in any medium, provided the ordetection of several respiratory pathogens; however, their
poor performance for detecting HAdV emphasizes the
need for single target detection [15,17,19]. Adenovirus-
specific NAATs have been challenged by the diversity of
HAdV species, which now include more than 60 different
types [20,21]. Commercial qualitative and quantitative
NAATs are available for the detection of all HAdV species
and most types, yet these are cost prohibitive for many la-
boratories. “In-house” real-time PCR assays are relatively
inexpensive alternatives to commercial NAATs that pro-
vide rapid and accurate results [7,17,18,21-26]. Wong and
collaborators [18] developed an in-house real-time PCR
assay that has been designed for the detection of all HAdV
species. It has been extensively validated using a variety of
clinical specimens [17,18].
In addition to the PCR reaction itself, extraction of nu-
cleic acids prior to PCR is also a substantial contributor
to cost. Recently, a crude mechanical lysis using silica
glass beads (i.e. homogenization) and heat treatment was
shown to recover herpes simplex virus DNA from swabs
submitted in universal transport media (UTM) [27,28].
While defying the traditional paradigm of specimen pro-
cessing for molecular testing, homogenization with heat
treatment was shown to be a cost effective alternative to
nucleic acid extraction. This study evaluated whetherl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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In patients suspected of respiratory or conjunctivitis,
flocked nasopharyngeal or ocular swabs, respectively,
were submitted for adenovirus detection. Swabs were
collected by clinicians at the Capital Health District
Authority (CDHA) and were submitted to the CDHA
microbiology laboratory (Halifax, NS, Canada) between
April 2010 and March 2012. The swabs were transported
in 3 ml of UTM (Copan Diagnostics Inc., Murrieta, CA)
and kept at 4°C for no more than 24 hours prior to pro-
cessing. Viral cultures were performed as part of routine
diagnostic testing by experienced technologists. Follow-
ing virus culture, specimens were transferred in aliquots
into cryotubes (without any identifiable patient informa-
tion) and the anonymized specimen tubes were archived
at −80°C for retrospective molecular analyses. Twenty-
seven virus culture-positive specimens and 169 virus
culture-negative specimens were randomly selected and
tested for the presence of HAdV using a well established
in-house real-time PCR assay [18] following recovery of
viral DNA was recovered by homogenization with heat
treatment or automated nucleic acid extraction.
Ethical considerations
The World Medical Association (WMA) Declaration of
Helsinki is a statement of ethical principles for medical
research involving human subjects, including research
on identifiable human material and data. Since the pur-
pose of this clinical validation was quality improvement
of the laboratory detection of adenovirus and relied
exclusively on anonymous human biological materials
that did not use or generate identifiable patient informa-
tion, research ethics board (REB) review was not re-
quired based on Chapter 2, article 2.4 of the Tri-Council
Policy Statement: Ethical Conduct for Research Involv-
ing Humans (2nd edition).
Viral culture
Viral cultures were performed as part of routine diag-
nostic testing by experienced technologists in the CDHA
microbiology laboratory (Halifax, NS, Canada). Briefly,
500 μl of specimen was inoculated onto cultured A549
cells (ATCC CCL-185), incubated at 37°C in a 5% CO2
atmosphere, and monitored daily for the presence of
characteristic cytopathic effect (CPE) [29]. If CPE was
observed, cells were fixed with acetone and stained
using specific fluorescein isothiocyanate (FITC)-labeled
monoclonal antibodies in the D2 Ultra DFA reagent kit(Diagnostic Hybrids, Athens, OH). In absence of CPE,
cells were fluid changed on day 7 and incubated for an
additional 7 days. On day 14, the culture was discontinued
and a terminal stain was performed. A549 cells were
propagated in Nutrient Mixture F-12 Ham with L-
glutamine (Sigma-Aldrich Canada Ltd., Oakville, ON)
supplemented with 1% fetal calf serum (Hyclone, Thermo
Fisher Scientific, Ottawa, ON), 2 μg/ml amphotericin B
(Sigma-Aldrich), 25 μg/ml ampicillin (Novapharm Ltd,
Toronto, ON), and 1 mg/ml vancomycin (Sigma-Aldrich).
For quantification, 10-fold dilutions of HAdV-C,
type 6 (strain Tonsil 99, ATCC VR-6) were inoculated
onto 96-well plates in volumes of 100 μl. Cells were
maintained as described above and after 14 days were
subjected to direct immunofluorescence (DFA) to de-
termine the 50% tissue culture infective dose (TCID50).
Results were expressed as TCID50/ml and represent 8
replicates obtained in four independent experiments
(n = 32).
Homogenization with heat treatment
Prior to molecular testing, viral DNA was recovered from
specimens using either homogenization with heat treat-
ment as previously described [27], or using a commercial
nucleic acid extraction as recommended by the manufac-
turer. For homogenization, 500 μl of specimen and 0.5 g
of various sized acid-washed silica beads: ≤106 μm;
150–212 μm; 719–1180 μm at a ratio of 3:2:1 (Sigma-
Aldrich, Oakville, ON) were placed on a Fastprep-24
homogenizer (MP BioMedicals, Solon, OH) at 6.5 m/s
for 45 s. Following a brief centrifugation at 14,000 × g
for 1 min, 200 μl of the supernatant was diluted in two
volumes of TE buffer (10 mM Tris–HCl, 1 mM EDTA,
pH 8.0). The homogenate was then heated at 95°C for
15 min, cooled to room temperature, and 5 μl was
subjected to adenovirus real-time PCR.
Nucleic acid extraction
Automated extractions were performed on 200 μl of spe-
cimen using a MagNA Pure Total Nucleic Acid Isolation
kit (Roche Diagnostics, Mannheim, Germany) on a Roche
MagNAPure LC instrument. The elution volume was
100 μl. Specimens with discordant results during method
comparison were subjected to a manual DNA extraction
using a QIAamp DNA Blood Mini kit (Qiagen, Toronto,
ON) with a sample volume of 200 μl. The DNA was eluted
in 100 μl, and concentrated 10-fold using a Qiagen
MinElute PCR purification kit. Plasmid DNA, used for the
internal control, was purified from a 5 ml overnight cul-
ture using a QIAprep Spin Miniprep kit (Qiagen) as
recommended by the manufacturer. For molecular typing,
amplicon was purified using a QIAquick Gel Extraction
Kit (Qiagen) with a final elution volume of 50 μl. All nu-
cleic acid extractions were performed using manufacturers’
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ing extraction and aliquots were placed at −80°C for long-
term storage.In-house real-time PCR
The real-time PCR has been extensively validated using
respiratory specimens [18]. To facilitate workflow in the
CDHA microbiology laboratory (Halifax, Nova Scotia,
Canada), the in-house assay was optimized for amplifi-
cation and detection on a Roche LightCycler 2.0 plat-
form. Real-time PCR was performed as duplex reactions
with primers and probes (Table 1) targeting the adeno-
virus hexon gene and an exogenous internal control.
For adenovirus, two sets of primers and probes were
used to span the genetically diverse adenovirus types
[17,18]. Primers were synthesized by Sigma Genosys
(Oakville, ON). Probes for adenovirus and the internal
control were purchased from BioSearch Technologies
(Novato, CA) and TIB MOLBIOL LLC (Adelphia, NJ),
respectively.
The internal control, termed pGFP, is added to each
reaction to monitor for the presence of PCR inhibitors.
pGFP is a pMK-derived plasmid with a fragment of the
gene encoding green fluorescence protein (GFP). The con-
struct was synthesized, assembled, and transformed intoTable 1 Nucleotide sequences of primers and probes
used in this study
Name Sequence (5′ to 3′) Reference
AdV2F CCA GGA CGC CTC GGA GTA [18]
AdV2R AAA CTT GTT ATT CAG GCT GAA GTA CGT [18]
AdV2pr FAM- AGT TTG CCC GCG CCA CCA CCG – BHQ1* [18]
AdV4F GGA CAG GAC GCT TCG GAG TA [18]
AdV4R CTT GTT CCC CAG ACT GAA GTA GGT [18]
AdV4pr FAM- CAG TTC GCC CGY GCM ACA G – BHQ1* [18]
FGFP TGA TAC CCT TGT TAA TAG A This study
RGFP ATT GTG TGA GTTATA GTT G This study
GFPpr1 GGT ATT GAT TTT AAA GAA GAT GG – FAM** This study
GFPpr2 LC705 – CAT TCT TGG GCA CAA ATT GGA- Ph** This study
AD1SEQ CTG ATG TAC TAC AAC AGC ACT GGC AAC
ATG GG
[32]
AD2SEQ GCG TTG CGG TGG TGG TTA AAT GGG TTT
ACG TTG TCC AT
[32]
F14MUT TCT GCG GGT AAT TTA CTA ACT AG This study
R14MUT ATC TCC TGT GTT CCA GGA CCA This study
* The hydrolysis probes were labeled with 6-carboxyfluorescein (FAM) at the
5’end; however, the 3’end was labeled with a Black Hole Quencher 1 (BHQ1)
instead of the carboxytetramethyl-rhodamine (TAMRA) quencher previously
described [18].
** Abbreviations for the hybridization probes targeting the internal control
(pGFP) are as follows: [FAM], 6-carboxyfluorescein; [LC705], LightCycler-Red
705; Ph, 3′-phosphate.Escherichia coli K12 by Life Technologies (Burlington,
ON). The final construct was verified by DNA sequencing
and restriction endonuclease digestion. E. coli harboring
pGFP was inoculated into Luria Bertani broth sup-
plemented with 50 μg/ml kanamycin. Plasmid DNA was
purified from a 5 ml overnight culture and plasmid
DNA was quantified by spectrophotometry. Ten-fold
serial dilutions were used as template for the in-house real-
time PCR. An inverse linear relationship (y = −3.3916× +
40.275; R2 = 0.9982) was generated by plotting crossing
points (Cp) values against plasmid concentration (data not
shown). The linear range spanned Cp values ranging from
7 to 37, corresponding to concentrations of 100 to 109 cop-
ies per μl, respectively. For each PCR reaction, approxi-
mately 2000 copies were added.
Real-time PCR assay was performed using the Light-
Cycler DNA Master HybProbe kit (Roche Diagnostics)
in 20 μl reactions consisting of: 5 μl of template, 1 ×
LightCycler FastStart mix, 3 mM MgCl2; 0.5 units of
heat-labile uracil-N-glycosylase [30]; 5 μl the internal
control at 400 copies/μl; 400 nM of each adenovirus pri-
mer (AdV2F, AdV2R, AdV4F, AdV4R) and 200 nM of
probe (AdV2pr and AdV4pr); and 500 nM of each pGFP
primer (FGFP and RGFP) and 300 nM of each probe
(GFPpr1 and GFPpr2) (Table 1). Amplification and
detection were performed using the LightCyler 2.0 in-
strument under the thermocycling conditions described
for the Roche HSV-1/2 detection kit: initial activation at
95°C for 10 min, followed by 45 amplification cycles of
denaturation at 95°C for 10 s, annealing at 55°C for 15 s,
and elongation at 72°C for 15 s. Following amplification,
melting temperature (Tm) analysis was performed by
measuring the fluorescent signal during the following
cycling profile: 95°C for 0 s, 40°C for 60 s, and 80°C for
0 s with a 0.2°C/s transition. Fluorescence was acquired
at the annealing stage during amplification and continu-
ously during the melting curve. Cp and Tm values were
determined using software provided by the manufac-
turer. The 530 nm (adenovirus) and 705 nm (pGFP)
channels were analyzed for presence or absence of tar-
get. PCR inhibition was suspected by either loss of posi-
tivity in the 705 nm channel, or a shift in Cp values
greater than two standard deviations (Cp ≥ 1.0) from the
value obtained with the negative control.
Commercial real-time PCR
To resolve discrepant results obtained between the in-
house PCR assay and virus culture, or quantify the
adenovirus DNA during evaluation of the analytical sen-
sitivity, the Adenovirus R-Gene kit (Argene Inc., Sherley,
NY) was used according to the manufacturer’s protocol
following a manual DNA extraction. This internally con-
trolled quantitative real-time PCR assay targets the
hexon gene of adenovirus, and is validated for detection
Table 2 Organisms used for the specificity panel





HAdV-A, type 31 + +
HAdV-B, type 3 + +
HAdV-B, type 7 + +
HAdV-B, type 14 + +
HAdV-B type 34 + +
HAdV-C, type 1 + +
HAdV-C, type 2 + +
HAdV-C, type 6 + +
HAdV-D, type 8 + +
HAdV-D, type 10 + +
HAdV-D, type 20 + +
HAdV-D, type 26 + +
HAdV-D, type 29 + +
HAdV-E, type 4 + +
HAdV-F, type 40 + +
Influenza A (pandemic H1N1,
seasonal H1N1 and seasonal
H3N2)
- -







(types A and B)
- -
Human coronaviruses (229E,
OC43, NL63, and HKU1)
- -
Human metapneumovirus - -
Rhinovirus (A, B or C) - -
Human bocavirus - -
Human herpesvirus (types
1–5, 6a, 6b, 7 and 8)
- -
Streptococcus pneumoniae - -
Haemophilus influenzae - -
Moraxella catarrhalis - -
Legionella pneumophila - -
Mycoplasma pneumoniae - -
Staphylococcus aureus - -
Staphylococcus epidermidis - -
Pseudomonas aeruginosa - -
Escherichia coli - -
Neisseria gonorrhoeae - -
Chlamydia trachomatis - -
*Virus and bacterial strains were obtained from the microbiology laboratory at
CDHA (Halifax, NS) or the Provincial Laboratory for Public Health
(Calgary, Alberta).
Al-Siyabi et al. Virology Journal 2013, 10:184 Page 4 of 12
http://www.virologyj.com/content/10/1/184of types 1 to 52 [7]. The kit contains: a ready-to-use pre-
mix contains (primers, probe, polymerase, and buffer)
needed for amplification, 4 quantification standards (at
50, 500, 5,000, and 50,000 copies/reaction), and a
sensitivity-control at 10 copies/reaction. Results were
expressed as the number of copies per reaction.
Analytical specificity, limit of detection, and
reproducibility
The analytical specificity was first determined in silico by
performing a Basic Local Alignment Search Tool (BLAST)
for primers, probes, and entire amplicon sequences using
the National Center for Biotechnology Information web-
site (http://www.ncbi.nlm.nih.gov). In addition, high titer
nucleic acids were extracted from a panel of microorgan-
isms chosen based on their ability to cause similar diseases
or their potential for being found in the clinical specimen
as a pathogen or normal flora (Table 2). To test for assay
inclusivity, adenoviruses spanning the various species and
types were tested by the in-house real-time PCR: [HAdV-
A type 31; HAdV-B types 3, 7, 14, 34; HAdV-C types 1, 2,
and 6; HAdV-D (type 8, 10, 20, 26, and 29); HAdV-E type
4, HAdV-F type 40] (Figure 1 and Table 2).
The analytical sensitivity (or limit of detection, LoD)
of the homogenization with heat treatment or nucleic
acid extraction, in combination with the real-time PCR,
was determined using 10-fold serial dilutions (in UTM)
of a cultured HAdV-C type 6. Each dilution was simul-
taneously processed by both extraction methods, and an
aliquot immediately inoculated onto A549 cells for virus
culture. The LoD was defined by Probit analysis [31]
using triplicate values obtained in four independent ex-
periments by two different operators (n = 24). Each virus
dilution was expressed as TCID50/ml in the original
sample. The virus dilutions were also quantified using a
commercial real-time PCR and expressed as target copies/
reaction for each assay. Intra- and inter-assay reproduci-
bility were calculated for each dilution and expressed as %
coefficients of variation (%CV).
Method comparison
The performance of each method was compared to a
modified gold standard to determine sensitivity, specifi-
city, accuracy and precision. A case was defined by con-
cordant results (positive or negative) between at least
two assays. To resolve discrepant results obtained be-
tween the in-house real-time PCR assay and virus cul-
ture, DNA was extracted manually and was subjected to
commercial real-time PCR.
Molecular typing of positives specimens
The 27 virus culture-positive specimens were subjected
to PCR targeting the conserved segments surrounding
the hypervariable region 7 (HVR7) of the hexon gene
Figure 1 Phylogenetic tree derived from hexon gene sequences. The HAdV types used in the specificity panel are indicated by arrows.
Clades are shaded to depict species A to F.
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using illustra Hot Start Ready-to-go (RTG) beads (GE
Healthcare UK Ltd., Bukinghamshire, UK), supplemented
with 1 μM of each primer (AD1SEQ and AD2SEQ;
Table 1), and an additional 0.5 mMMgCl2. Thermocycling
conditions were as follows: initial activation at 95°C for
10 min; 40 cycles of denaturation at 95°C for 1 min;
annealing at 50°C for 1 min; extension at 72°C for 1 min;
and a final extension of 5 min at 72°C. Amplifications
were performed on a DNA engine dyad thermocycler
(Bio-Rad Laboratories Ltd., Mississauga, Ontario, Canada)
and amplicons were resolved by 1.5% agarose gel elec-
trophoresis with ethidium bromide staining. Amplicons
corresponding to the expected size (approximately
600 bp) were excised using a sterile scalpel and were
purified using a QIAquick Gel Extraction Kit (Qiagen).
Purified amplicon DNA was submitted for DNA
sequencing at the York University Core Molecular Biol-
ogy and DNA Sequencing Facility (Toronto, Ontario,
Canada). Sequencing was performed using BigDyeTerminator chemistry on the Applied Biosystems
3130 × L DNA Sequencer. Type designation was under-
taken by BLAST analysis, and confirmed by comparison
to a database generated from sequences obtained from
GenBank [32]. Sequence analysis and multiple sequence
alignments (ClustalW analysis) were performed using
the Seqman and Megalign components of Lasergene 6
software (DNASTAR, Madison, WI). The phylogenetic
tree was inferred using a neighbor-joining (NJ) method
with bootstrapping analysis for n = 1000.
Statistical analysis
Chi-square and two-tailed Fisher’s exact tests were used to
compare proportions in 2-by-2 contingency tables. Confi-
dence intervals (99%) for the estimated parameters are
computed by a general method based on “constant chi-
square boundaries” [33]. Agreement between assays was
measured using kappa statistics. The Statistical Package
for Social Sciences (SPSS) software v.10 was used and P ≤
0.01 was used to denote a statistically significance.
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Analytical specificity, limit of detection, and
reproducibility
BLAST searches of primers and probes targeting the
adenovirus hexon gene the internal control sequences
revealed that these were highly specific targets. In fact,
no cross reactions were observed with high-titer nucleic
acids extracted from other respiratory viruses or bacteria
(Table 2). The in-house real-time assay was able to
detect serogroups A to F, including a variety of genetic-
ally diverse types: 1, 2, 3, 4, 6, 7, 10, 20, 26, 31, and 40
(Figure 1 and Table 2).
As seen in Figure 2, the performance of the in-
house PCR following the homogenization- or nucleic
acid extraction-based protocols was equivalent. For
each method, overlapping linear relationships were ob-
served (y = −3.7668 × + 44.733; R2 = 0.9987 compared
to y = −3.9058 + 45.313; R2 = 0.9985, respectively) that
spanned eight orders of magnitude with Cp values
ranging from 14 to 40 (Figure 2A). The intra- and
inter-assay reproducibility of the real-time PCR follow-
ing homogenization and heat treatment ranged from
0.03 to 4.80%, and 1.45 to 3.79%, respectively. Simi-
larly, intra- and inter-assay reproducibility of following
the nucleic acid extraction protocol ranged from 0.2
to 2.15% and 0.85 to 3.15%. As expected, the highest
%CV values observed for both methods were with
virus dilutions near the LoD.
For HAdV-C type 6, the LoD for virus culture was 0.2
TCID50/ml. The in-house real-time PCR was reprodu-
cibly positive following nucleic acid extraction or
homogenization with viral stock dilutions corresponding
to 0.02 TCID50/ml (24/24 and 24/24, respectively), and
positive PCR reactions were frequently observed using
virus dilutions of 0.002 TCID50/ml (20/24 and 21/24,
respectively). Virus stock dilutions were quantified
using commercial real-time PCR assay, and the LoD for
homogenization or nucleic acid extraction-based proto-
cols were shown to be approximately equivalent
(Figure 2). With a probability of 95%, the LoD for the
homogenization- and nucleic acid extraction-based pro-
tocols were 12 copies/reaction (log10 = 1.08) and 18
copies/reaction (log10 = 1.08), respectively (Figure 2B).
Dilutions corresponding to the LoD for virus culture
were also quantified by real-time PCR and estimated at
approximately 380 copies/reaction (Figure 2B).
Method comparison using clinical specimens
Of the 196 clinical specimens, 157 concordant negative
and 27 concordant positive results were obtained when
comparing virus culture to the in-house PCR following
either of the two extraction methods (Figure 3A and
Table 3). Real-time PCR generated 12 additional positive
results that were later resolved as true positives using amanual DNA extraction and a commercial real-time
PCR (Figure 3A). All 12 PCR-positive culture-negative
results were detected following homogenization proto-
col, whereas 11 were detected following nucleic acid
extraction (Figure 3A). The single discordant result be-
tween the molecular assays had a Cp value of 37.22,
suggesting that it may be attributed to sampling error
(Poisson distribution) at low concentrations of template
[34]. Since the internal control also failed to amplify in
this sample, the negative result could also be attributed
to PCR inhibition. Upon repeat processing by automated
and manual nucleic acid extractions, positive results
were obtained. Therefore, the original specimen result
was considered a false negative. Overall, compared to
the modified gold standard, the sensitivity of the in-
house real-time PCR following homogenization with
heat treatment or nucleic acid extraction was approxi-
mately equivalent at 100% (89.7–100%) and 97.4%
(86.4–97.4%), respectively (Table 3). In contrast, the sen-
sitivity of virus culture was only 69.7% (56.0–69.2%)
(Table 3). The accuracy of each method was 100%
(95.6–100%), 99.5% (95.1–99.5%), and 93.9% (88.6–
93.9%), respectively (Table 3). All assays showed a high
degree of specificity and precision (Table 3).
When comparing Cp values for the positive results
obtained with the real-time PCR following both extrac-
tion methods, a linear relationship was observed (y =
0.9416 × + 4.5731; R2 = 0.9756) (Figure 3B). Cp values
for homogenization with heat treatment were consist-
ently higher than those obtained using the nucleic acid
extraction; however, no significant differences in sensi-
tivity (analytical or clinical) were observed (Figure 2 and
Table 3). As expected, virus culture-positive specimens
had positive PCR results with low Cp values, whereas
the virus culture-negative specimens had PCR-positive
results with Cp values greater than 30 (Figure 3B).
Molecular typing of positives specimens
DNA extracted from the 39 real-time PCR positive spec-
imens were subjected to a conventional PCR targeting
the conserved segments surrounding the HVR7 of the
hexon gene [32]. Successful sequences were obtained
from DNA extracted from the 27 specimens that were
both virus culture and real-time PCR-positive. A type
could be assigned using multiple sequence alignment of
sequences derived from GenBank, as previously de-
scribed [32]. Individual BLAST analysis yielded similar
results. Three serogroups were observed: B (types 3, 7,
14, and 34), C (types 2 and 6), and D (types 8, 10, and
29). The predominant types observed were: 3 (37.0%), 29
(18.5%), 2 (14.8%), and 8 (1.1%). The conventional PCR
was unable to amplify the target sequences from DNA
extracted from the 12 virus culture-negative/real-time
PCR-positive specimens. The Cp values for these
AB
Figure 2 Analytical sensitivity of the in-house real-time PCR. Prior to amplification, 10-fold serial dilutions of HAdV-C type 6 were processed
by homogenization and heat treatment (open circles, solid line), or nucleic acid extraction (filled squares, dashed line). In both cases, equivalent
results were obtained in respect to: A) the linear range; and B) the LoD determined by Probit analysis (n = 24). At a probability of 95%, the LoD
for the homogenization- and nucleic acid extraction-based protocols were 12 copies/reaction (log10 = 1.08) and 18 copies/reaction (log10 = 1.08),
respectively. The same dilutions used for inoculate virus culture and DFA staining (indicated by open triangles, dotted line) were also quantified
and demonstrated a LoD of approximately 380 copies/ml (log10 = 2.58).
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quantities of virus were present (Figure 3).
Mutation analysis in adenovirus type 14
DNA sequencing was also used to distinguish the
prototypic HAdV type 14p (strain De Wit) from newlyemerged type 14p1. Adenovirus type 14p1 has been
associated with severe disease in Europe and the North
America [2-5]. While the hexon HVR7 sequences obtained
in this study share 100% identity with HAdV type 14p1,
only two mutations (G1341A and G1491A) separate types
14p1 from 14p in this region. To further characterize the
AB
Figure 3 Comparison of the positive results obtained with virus culture and the two molecular assays. A) In each field of the Venn
diagram, the number of positive specimens is given. *All virus culture-negative/PCR-positive specimens were resolved as true positives by a
commercial DNA extraction and real-time PCR. B) The Cp values obtained by real-time PCR in 27 adenovirus-positive specimens following
homogenization- or nucleic acid extraction-based protocols displayed a correlation of 97.6% (solid line). The dashed line represents a correlation
of 100%. The dotted oval highlights Cp values obtained with specimens that were PCR-positive but culture-negative.
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F14MUT and R14MUT (Table 1), using reaction condi-
tions, thermocycling parameters, and DNA sequencing
as described for the molecular typing. Compared to
wild-type 14p, the fiber knob gene of HAdV type 14p1
displays a 6-bp deletion (referred to as the K250-E251
deletion) [4,35,36]. The adenovirus type 14 from this
study harbored the characteristic 6-bp deletion, consist-
ent with HAdV type 14p1 (Figure 4).Monitoring for PCR inhibition
An exogenous internal control was used in this study
which is non-competitive (contains a primer pair that
does not target adenovirus). The addition of the internal
control and primers and probes to the in-house PCR re-
action did affect the analytical sensitivity of the assay
(data not shown). Since the internal control was added
at the level of PCR, both extraction methods could be
directly evaluated for the presence of PCR inhibitors.











Virus culture 69.2 (56.0-69.2) 100 (96.7-100) 93.9 (88.6-93.9) 100 (80.8-100) 0.783 (0.596-0.783)
Nucleic acid extraction and real-time PCR 97.4 (86.4-97.4) 100 (97.3-100) 99.5 (95.1-99.5) 100 (88.6-100) 0.984 (0.844-0.984)
Homogenization with heat treatment and
real-time PCR
100 (89.7-100) 100 (97.4-100) 100 (95.6-100) 100 (89.7-100) 1.000 (0.871-1.000)
* A case was defined by concordant results (positive or negative) between at least two assays. A manual nucleic acid extraction and commercial real-time PCR was
used to resolve discrepant results. TP true positive, TN true negative, FP false positive, FN false negative, CI confidence interval.
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homogenization is a crude method to recover viral DNA
and may not sufficient to remove or inactivate PCR inhibi-
tors. Amplification of the internal control in adenovirus-
negative specimens is consistent with a true negative
result and not simply attributed to PCR inhibition. PCR
inhibition was suspected by either loss of positivity in
the 705 nm channel, or a shift in Cp values greater than
two standard deviations (which corresponds to approxi-
mately ±1.0 Cp) from the value obtained with the
negative control. This value was established previously,
where the internal control Cp values from 150 consecu-
tive HSV-negative specimens were compared by homo-
genization and heat treatment or nucleic acid extraction
[27]. This cutoff value remains true for the internal con-
trol used in this study.
Since the in-house PCR was performed as a duplex
with an internal control added at the level of PCR, the 196
clinical specimens processed following homogenization
and heat treatment or nucleic acid extraction could be
monitored directly for the presence of potential PCR in-
hibitors. Potential inhibitory substances were observed in
two distinct cases: the first was a specimen that had been
processed by homogenization with heat treatment, and
the second, in a specimen subjected to nucleic acid extrac-
tion. In both cases, PCR inhibition was not observed upon
repeat processing, suggesting either a processing error hadFigure 4 Human adenovirus fiber knob gene alignment. Compared to
visible in all HAdV type 14p1 sequences. Black arrows demarcate the K250-
HAdV type 14p1 sequences and also contains the 6-pb deletion. GenBank
GI:307147785)]; USA 2007 [Portland/2971/2007 (FJ841909.1 GI:268588942)];
Canada 2001b [Canada/RV1360/2011 (JQ815083.1 GI:395135723)]; Canada 2
1974 [Netherlands/16845/1974 (FJ841910.1 GI:268588944)]; de Wit strain AToccurred or the PCR inhibitor was labile [37]. Therefore,
PCR inhibition could not be proven or excluded. As a re-
sult, the rate of possible PCR inhibition with either extrac-
tion method was equivalent at 0.51% (1/196).Cost analysis
At CDHA (Halifax, NS, Canada), the average number of
specimens submitted yearly for adenovirus testing is 312
(range 208 to 466 for years 2009 to 2012) and the turn-
around time for virus culture can be up to 14 days. A
cost analysis was performed that assumed a more prac-
tical approach of bi-weekly molecular testing (3–5 speci-
mens with positive, negative and reagent controls).
Excluding labor, the average cost of a commercial PCR
following nucleic acid extraction would range from $45
to $55 (CAD) per specimen. In comparison, the in-
house real-time PCR following a nucleic acid extraction
would reduce the cost approximately ~2-fold ($21.44 to
$25.97). Replacement of the nucleic acid extraction with
the homogenization-base protocol further reduces the
cost ~2-fold ($8.84 to $10.97), which is comparable to
the average cost of virus culture ($9.47 to 11.64). The
time require for bi-weekly processing for either molecu-
lar methods is ~5 h/week, which is far lower than the
time required for weekly maintenance and processing of
specimens using cell culture and DFA staining.the prototypic type 14p (De Wit) sequence, a 6-bp deletion is clearly
E251 deletion. The query sequence from this study aligns with the
numbers are as follows: Ireland 2009 [Dublin/2009 (HQ163915.1/
Canada 2001a [Canada/RV1368/2011 (JQ815084.1 GI:395135725)];
011c [Canada/RV1370/2011 (JQ815085.1 GI:395135727)]; Netherlands
CC VR-1091 (AY803294.1 GI:57115621).
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NAATs like real-time PCR have revolutionized the de-
tection of human pathogens in clinical microbiology
laboratories. Rapid specimen throughput and excellent
performance characteristics make them an appealing al-
ternative to traditional culture methods; however, cost
limits their use in many clinical laboratories. Both the
recovery of nucleic acids using extraction and the PCR
reaction itself contribute to the cost. We have shown that
combining a crude extraction method like homogenization
with heat treatment [27] and an in-house real-time PCR
[18] is a cost effective strategy for the detection HAdV
from swabs submitted in UTM. Homogenization uses
multidirectional motion to disrupt cells through contact
with silica beads and the heat treatment [27,28]. In com-
bination with a subsequent heat treatment to inactivate
heat-labile PCR inhibitors, this crude mechanical lysis had
been shown to be a cost-effective method to recover viral
DNA from swabs transported in UTM [27]. The perform-
ance characteristics of this approach were equivalent to
using traditional nucleic acid extraction and both molecu-
lar methods far exceeded those obtained with virus culture.
Replacing the nucleic acid extraction with the homo-
genization protocol did not affect the analytical (or clinical)
sensitivity of the real-time PCR (Figure 2 and Table 3).
Using dilutions of HAdV-C type 6, the LoD for the
homogenization protocol was approximately 12 copies/re-
action, was consistent with previously reported values (22–
33 copies/reaction) for HAdV types 2 and 4 [18]. This
analytical sensitivity is approximately 32-fold more sensitive
than the estimated LoD for virus culture. Furthermore,
positive results could be even obtained at 6 copies/reaction
with a probability of 87.5% (Figure 2B). While no significant
differences were observed between the molecular assays,
both demonstrated a high level of analytical sensitivity.
When comparing 196 clinical specimens using a
modified gold standard, the in-house PCR following
homogenization and heat treatment or nucleic acid ex-
traction demonstrated similar sensitivities of 100% and
97.4%, respectively (Table 3). This far surpasses the per-
formance of virus culture at 69.2%. The 30% increase in
positivity is consistent with the ~32-fold increase in ana-
lytical sensitivity and is not surprising since similar re-
sults were observed when transitioning other viruses
from culture to NAATs [38-41]. When comparing posi-
tive results from the in-house real-time PCR, Cp values
obtained following the homogenization protocol were
consistently higher than those obtained following nucleic
acid extraction (Figure 3B). However, the analytical and
clinical sensitivities of each assay were not significantly
different (Figure 2 and Table 3). It should be noted that
all virus culture-negative/PCR-positive specimens had
Cp values greater than 30, corresponding to viral loads
that fell below the LoD for virus culture (Figure 3B).The homogenization- or nucleic acid extraction-based
protocols both showed excellent analytical specificity,
with no cross-reactions from other organisms (Table 2).
Both methods were able to detect diverse HAdV types
spanning all the different species (Figure 1 and Table 2).
Of the virus culture-positive specimens, the most pre-
dominant types detected were 3, 29 and 2, belonging to
species B, D and C, respectively. These HAdV types are
well-recognized causes of acute respiratory tract and
ocular infections and are consistent with the distribution
reported by others regions in Canada [42,43]. Interest-
ingly, a variant of HAdV type 14, termed 14p1, has been
described as an emerging pathogen associated with
outbreaks and sporadic cases of acute respiratory disease
in Europe and the United States [2-5]. While most
recorded cases were mild infections, severe disease and
deaths have occurred. HAdV type 14p1 has a character-
istic 6-bp deletion (K250-E251) in the fiber knob gene
[4,35,36]. The adenovirus type 14 from this study was
consistent with type 14p1 and harbored these mutations
(Figure 4). While there has been a number of reports of
type 14p1 circulating in the US and Europe, this variant
has only once been reported in Canada [4]. The first
adenovirus 14p1 cases in Canada were reported from
Nova Scotia’s neighboring province, New Brunswick,
and included one fatality (Figure 4) [4]. The specimen
identified as 14p1 in this study was obtained from a fatal
case dating back to same time period as the New Bruns-
wick cases. Further epidemiological investigations are
underway. While severe and fatal cases associated with
type 14p1 have been reported, similar outcomes have
been reported with many other common HAdV types
[6,7,10,44]. The most likely culprit of disease severity is
the immune status of the host, not the adenovirus type
or species.
It should be noted that the thermocycling conditions
for the adenovirus PCR were modified to allow simul-
taneous processing of other real-time PCR assays (HSV
and VZV) in the CDHA microbiology laboratory [18].
Simultaneously processing of multiple PCR assays on
the same LightCycler instrument allows more efficient
batch testing when equipment availability is limited.
Interestingly, these modifications allowed the detection
of HAdV type 31 which had previously been problematic
on an ABI instrument [18]. Difference between assays
can be attributed to a numerous factors (i.e. instrumen-
tation, kits, etc.); however, the most likely explanation in
this case is the annealing temperature. Using the ori-
ginal PCR protocol [18], HAdV type 31 could only be
detected when the annealing temperature was reduced
from 60°C to 57°C [18]. The annealing temperature in
this study is 55°C. Using conditions described in this
study, the detection of HAdV type 31 has now been rep-
licated in both collaborating laboratories.
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homogenization was only performed using swabs in
UTM. Future experiments will need to examine whether
homogenization can be applied to other relevant specimen
types (urine, stool, blood and tissue); however, the real-
time PCR following a nucleic acid extraction has been
shown to be effective for this purpose [18,21]. Secondly,
the performance characteristics of homogenization may
vary between PCR assays and should not be implemented
without proper validation [27]. While homogenization
with heat treatment has shown to be effective for the re-
covery of viral DNA from HAdV (this study), HSV [27],
and varicella zoster virus, decreased sensitivity was ob-
served for enveloped RNA viruses like mumps and influ-
enza viruses ([24,45] LeBlanc, J. unpublished data).
Homogenization and heat treatment showed perform-
ance characteristics equivalent to a commercial nucleic
acid extraction for the detection of HAdVs. In combin-
ation with a sensitive in-house real-time PCR, homo-
genization with heat treatment generated results far
superior than virus culture, and at a comparable cost. By
modifying the thermocycling conditions to those used by
other assays in the CDHA microbiology laboratory, it
further streamlined workflow and facilitated transition
from virus culture to molecular testing. Compared to
virus isolation and propagation using culture, molecu-
lar testing also further reduces the risk of laboratory-
acquired infections [46]. Overall, homogenization with
heat treatment combined with a sensitive in-house
real-time PCR is a cost-effective method for the detec-
tion of HAdVs.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JL conceived the study. JL, TH and RT participated in its design and
coordination. TA, KB, and JL carried out the molecular testing. MW quantified
the adenovirus stocks and established TCID50 values. TA and KB performed
statistical analyses. JL analyzed the DNA sequencing results. RT, SW and KP
were involved in the phylogenetic analyses and typing of the adenoviruses
as well as preparing the specificity panels. All authors were involved in the
preparation of the manuscript. All authors have read and approved the final
manuscript.
Acknowledgements
We would like to thank members of Division of Microbiology, Department of
Pathology and Laboratory Medicine at CDHA (Halifax, Nova Scotia) for their
ongoing support and for funding for this project. In particular, we are
indebted to Wanda Brewer for the propagation and maintenance of A546
cells, and the various technologists responsible for routine virus culture.
Author details
1Division of Microbiology, Department of Pathology and Laboratory
Medicine, Capital District Health Authority Room 404B Mackenzie Building,
5788 University Ave., Halifax, NS B3H 1V8. 2Dalhousie University, Halifax, Nova
Scotia, Canada. 3Provincial Laboratory for Public Health, Calgary, Alberta,
Canada. 4University of Calgary, Calgary, Alberta, Canada.
Received: 27 February 2013 Accepted: 23 May 2013
Published: 7 June 2013References
1. Mandell GL, Bennett JE, Dolin R: Mandell, Douglas, and Bennett’s principles
and practice of infectious diseases. 7th edition. Philadelphia, PA: Churchill
Livingstone/Elsevier; 2009.
2. Lewis PF, Schmidt MA, Lu X, Erdman DD, Campbell M, Thomas A, Cieslak
PR, Grenz LD, Tsaknardis L, Gleaves C, Kendall B, Gilbert D: A community-
based outbreak of severe respiratory illness caused by human
adenovirus serotype 14. J Infect Dis 2009, 199:1427–1434.
3. Louie JK, Kajon AE, Holodniy M, Guardia-LaBar L, Lee B, Petru AM, Hacker JK,
Schnurr DP: Severe pneumonia due to adenovirus serotype 14: a new
respiratory threat? Clin Infect Dis 2008, 46:421–425.
4. Girouard G, Garceau R, Thibault L, Oussedik Y, Bastien N, Li Y: Adenovirus
serotype 14 infection, New Brunswick, Canada, 2011. Emerg Infect Dis
2013, 19:119–122.
5. O’Flanagan D, O’Donnell J, Domegan L, Fitzpatrick F, Connell J, Coughlan S, De
Gascun C, Carr MJ: First reported cases of human adenovirus serotype 14p1
infection, Ireland, October 2009 to July 2010. Euro Surveill 2011, 16:19801.
6. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A: Treatment of
adenovirus infections in patients undergoing allogeneic hematopoietic
stem cell transplantation. Clin Infect Dis 2001, 32:1290–1297.
7. Jeulin H, Salmon A, Bordigoni P, Venard V: Comparison of in-house real-
time quantitative PCR to the Adenovirus R-Gene kit for determination of
adenovirus load in clinical samples. J Clin Microbiol 2010, 48:3132–3137.
8. Lankester AC, van Tol MJ, Claas EC, Vossen JM, Kroes AC: Quantification of
adenovirus DNA in plasma for management of infection in stem cell
graft recipients. Clin Infect Dis 2002, 34:864–867.
9. Leen AM, Myers GD, Bollard CM, Huls MH, Sili U, Gee AP, Heslop HE, Rooney
CM: T-cell immunotherapy for adenoviral infections of stem-cell
transplant recipients. Ann. N.Y. Acad Sci 2005, 1062:104–115.
10. Lenaerts L, De Clercq E, Naesens L: Clinical features and treatment of
adenovirus infections. Rev Med Virol 2008, 18:357–374.
11. Schilham MW, Claas EC, van Zaane W, Heemskerk B, Vossen JM, Lankester AC,
Toes RE, Echavarria M, Kroes AC, van Tol MJ: High levels of adenovirus DNA in
serum correlate with fatal outcome of adenovirus infection in children after
allogeneic stem-cell transplantation. Clin Infect Dis 2002, 35:526–532.
12. Symeonidis N, Jakubowski A, Pierre-Louis S, Jaffe D, Pamer E, Sepkowitz K,
O’Reilly RJ, Papanicolaou GA: Invasive adenoviral infections in T-cell
-depleted allogeneic hematopoietic stem cell transplantation: high
mortality in the era of cidofovir. Transpl Infect Dis 2007, 9:108–113.
13. Dabisch-Ruthe M, Vollmer T, Adams O, Knabbe C, Dreier J: Comparison of
three multiplex PCR assays for the detection of respiratory viral
infections: evaluation of xTAG respiratory virus panel fast assay,
RespiFinder 19 assay and RespiFinder SMART 22 assay. BMC Infect Dis
2012, 12:163.
14. LeBlanc JJ, Li Y, Bastien N, Forward KR, Davidson RJ, Hatchette TF: Switching
gears for an influenza pandemic: validation of a duplex reverse
transcriptase PCR assay for simultaneous detection and confirmatory
identification of pandemic (H1N1) 2009 influenza virus. J Clin Microbiol
2009, 47:3805–3813.
15. Loeffelholz MJ, Pong DL, Pyles RB, Xiong Y, Miller AL, Bufton KK,
Chonmaitree T: Comparison of the FilmArray respiratory panel and
prodesse real-time PCR assays for detection of respiratory pathogens.
J Clin Microbiol 2011, 49:4083–4088.
16. Mahony J, Chong S, Merante F, Yaghoubian S, Sinha T, Lisle C, Janeczko R:
Development of a respiratory virus panel test for detection of twenty
human respiratory viruses by use of multiplex PCR and a fluid
microbead-based assay. J Clin Microbiol 2007, 45:2965–2970.
17. Pabbaraju K, Wong S, Fox JD: Detection of adenoviruses. Methods Mol Biol
2011, 665:1–15.
18. Wong S, Pabbaraju K, Pang XL, Lee BE, Fox JD: Detection of a broad range
of human adenoviruses in respiratory tract samples using a sensitive
multiplex real-time PCR assay. J Med Virol 2008, 80:856–865.
19. Pabbaraju K, Tokaryk KL, Wong S, Fox JD: Comparison of the Luminex
xTAG respiratory viral panel with in-house nucleic acid amplification
tests for diagnosis of respiratory virus infections. J Clin Microbiol 2008,
46:3056–3062.
20. Aoki K, Benkö M, Davison AJ, Echavarria M, Erdman DD, Harrach B, Kajon AE,
Schnurr D, Wadell G, Members of the Adenovirus Research Community:
Toward an integrated human adenovirus designation system that
utilizes molecular and serological data and serves both clinical and
fundamental virology. J Virol 2011, 85:5703–5704.
Al-Siyabi et al. Virology Journal 2013, 10:184 Page 12 of 12
http://www.virologyj.com/content/10/1/18421. Buckwalter SP, Teo R, Espy MJ, Sloan LM, Smith TF, Pritt BS: 2012. Real-time
qualitative PCR for 57 human adenovirus types from multiple specimen
sources. J Clin Microbiol 2012, 50:766–771.
22. Chmielewicz B, Nitsche A, Schweiger B, Ellerbrok H: Development of a PCR-
based assay for detection, quantification, and genotyping of human
adenoviruses. Clin Chem 2005, 51:1365–1373.
23. Ebner K, Suda M, Watzinger F, Lion T: Molecular detection and
quantitative analysis of the entire spectrum of human adenoviruses by a
two-reaction real-time PCR assay. J Clin Microbiol 2005, 43:3049–3053.
24. Gu Z, Belzer SW, Gibson CS, Bankowski MJ, Hayden RT: Multiplexed, real-
time PCR for quantitative detection of human adenovirus. J Clin Microbiol
2003, 41:4636–4641.
25. Heim A, Ebnet C, Harste G, Pring-Akerblom P: Rapid and quantitative
detection of human adenovirus DNA by real-time PCR. J Med Virol 2003,
70:228–239.
26. Jones MS, Hudson NR, Gibbins C, Fischer SL: Evaluation of type-specific
real-time PCR assays using the LightCycler and J.B.A.I.D.S. for detection
of adenoviruses in species HAdV-C. PLoS One 2011, 6:e26862.
27. LeBlanc JJ, Heinstein CR, Hatchette TF: Homogenization with heat
treatment: a cost effective alternative to nucleic acid extraction for
herpes simplex virus real-time PCR from viral swabs. J Virol Methods 2012,
179:261–264.
28. Li R, Mock R, Huang Q, Abad J, Hartung J, Kinard G: A reliable and
inexpensive method of nucleic acid extraction for the PCR-based
detection of diverse plant pathogens. J Virol Methods 2008, 154:48–55.
29. Lipson SM, Poshni IA, Ashley RL, Grady LJ, Ciamician Z, Teichberg S:
Presumptive identification of common adenovirus serotypes by the
development of differential cytopathic effects in the human lung
carcinoma (A549) cell culture. FEMS Microbiol Lett 1993, 113:175–182.
30. LeBlanc J, Pettipas J, Campbell S, Davidson RJ, Hatchette TF: Uracil-DNA
glycosylase (UNG) influences the melting curve profiles of herpes simplex
virus (HSV) hybridization probes. J Virol Methods 2008, 151:158–160.
31. Finney DJ: Probit Analysis. 3rd edition. UK: Cambridge university press,
cambridge; 1971. ISBN 0-521-08041-X.
32. Sarantis H, Johnson G, Brown M, Petric M, Tellier R: Comprehensive
detection and serotyping of human adenoviruses by PCR and
sequencing. J Clin Microbiol 2004, 42:3963–3969.
33. Fleiss JL, Levin B, Paik MC: Logistic Regression. In Statistical methods for
rates and proportions. Edited by Shewart WA, Wilks SS. New York: John
Wiley & Sons; 2003. ISBN: 9780471526292.
34. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA: Quantitation of
targets for PCR by use of limiting dilution. Biotechniques 1992, 13:444–449.
35. Houng HS, Gong H, Kajon AE, Jones MS, Kuschner RA, Lyons A, Lott L, Lin
KH, Metzgar D: Genome sequences of human adenovirus 14 isolates
from mild respiratory cases and a fatal pneumonia, isolated during
2006-2007 epidemics in North America. Respir Res 2010, 11:116.
36. Zhang Q, Seto D, Zhao S, Zhu L, Zhao W, Wan C: Genome sequence of the
first human adenovirus type 14 isolated in China. J Virol 2012, 86:7019–7020.
37. Wilson IG: Inhibition and facilitation of nucleic acid amplification. Appl
Environ Microbiol 1997, 63:3741–3751.
38. Campbell S, Leblanc J, Pettipas J, Hatchette T, Davidson R: A comparison of
cell culture versus real-time PCR for the detection of HSV1/2 from
routine clinical specimens. Can J Infect Dis Med Microbiol 2008, 19:77–142.
39. Cooper RJ, Yeo AC, Bailey AS, Tullo AB: Adenovirus polymerase chain
reaction assay for rapid diagnosis of conjunctivitis. Invest Ophthalmol Vis
Sci 1999, 40:90–95.
40. Gharabaghi F, Tellier R, Cheung R, Collins C, Broukhanski G, Drews SJ,
Richardson SE: Comparison of a commercial qualitative real-time RT-PCR
kit with direct immunofluorescence assay (DFA) and cell culture for
detection of influenza A and B in children. J Clin Virol 2008, 42:190–193.
41. Räty R, Kleemola M, Melén K, Stenvik M, Julkunen I: Efficacy of PCR and
other diagnostic methods for the detection of respiratory adenoviral
infections. J Med Virol 1999, 59:66–72.
42. Alharbi S, Caeseele PV, Consunji-Araneta R, Zoubeidi T, Fanella S, Souid A,
Alsuwaidi AR: Epidemiology of severe pediatric adenovirus lower
respiratory tract infections in Manitoba, Canada, 1991-2005. BMC Infect
Dis 2012, 12:55.
43. Yeung R, Eshaghi A, Lombos E, Blair J, Mazzulli T, Burton L, Drews SJ:
Characterization of culture-positive adenovirus serotypes from
respiratory specimens in Toronto, Ontario, Canada: September 2007-
June 2008. Virol J 2009, 6:11.44. Kim YJ, Hong JY, Lee HJ, Shin SH, Kim YK, Inada T, Hashido M, Piedra PA:
Genome type analysis of adenovirus types 3 and 7 isolated during
successive outbreaks of lower respiratory tract infections in children.
J Clin Microbiol 2003, 41:4594–4599.
45. Leblanc JJ, Pettipas J, Davidson RJ, Tipples GA, Hiebert J, Hatchette TF:
Detection of mumps virus RNA by real-time one-step reverse
transcriptase PCR using the LightCycler platform. J Clin Microbiol 2008,
46:4049–4051.
46. Paragas J, Endy TP: Viral agents of human disease: biosafety concerns. In
Biological safety: principles and practices. 4th edition. Edited by Fleming DO,
Hunt DL. Washington DC: ASM Press; 2006:179–207.
doi:10.1186/1743-422X-10-184
Cite this article as: Al-Siyabi et al.: A cost effective real-time PCR for the
detection of adenovirus from viral swabs. Virology Journal 2013 10:184.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
